CDK9 and non-small cell lung carcinoma: Among the five miRNA indicators in this study, miR-1-3p has been reported to inhibit the proliferation of human NSCLC cells by negatively regulating its target gene cyclin dependent kinase 9 (CDK9), thus promoting the apoptosis of NSCLC cells (13).